Neogenomics (NEO) Revenue Growth (1y) (2011 - 2026)
Neogenomics (NEO) Revenue Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 10.49% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 5.54% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 9.66% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 10.01% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 8.74% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 38.82% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 9.44% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 4.48% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 10.21% |
| 10 | Neogenomics | 2.05 Bn | 1.90 Bn | 91.88 Mn | 11.21% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.21% |
| Mar 31, 2026 | 11.09% |
| Dec 31, 2025 | 10.56% |
| Sep 30, 2025 | 11.90% |
| Jun 30, 2025 | 10.23% |
| Mar 31, 2025 | 7.55% |
| Dec 31, 2024 | 10.57% |
| Sep 30, 2024 | 10.44% |
| Jun 30, 2024 | 11.97% |
| Mar 31, 2024 | 13.86% |
| Dec 31, 2023 | 12.15% |
| Sep 30, 2023 | 17.99% |
| Jun 30, 2023 | 17.47% |
| Mar 31, 2023 | 17.11% |
| Dec 31, 2022 | 10.32% |
| Sep 30, 2022 | 6.13% |
| Jun 30, 2022 | 2.75% |
| Mar 31, 2022 | 1.42% |
| Dec 31, 2021 | -0.21% |
| Sep 30, 2021 | -3.27% |